Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Continuous Infusion Ropivacaine Interscalene Blocks

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients will be eligible for inclusion in the study if they have a full-thickness rotator cuff tear that has been deemed reparable by preoperative MRI. They will be included in the study if they are medically stable to undergo the surgery and consent to involvement in the study.~Exclusion Criteria:~1. Prior surgery on the involved shoulder~2. Preoperative MRI suggesting that the rotator cuff tear is irreparable~3. Patients with known allergies to oxycodone, ropivacaine or a similar drug~4. Workman's compensation patients~5. Patients who do not fill out their visual analog scores or their medication diaries~6. Patients with labral or subscapularis tears requiring repair

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ropivacaine infusion (Type: ACTIVE_COMPARATOR): 270cc of Ropivacaine infusion at 5cc per hour. All patients will receive a reservoir for their catheters containing 280cc of either ropivacaine or saline that will infuse at a rate of 6cc per hour. The reservoirs will be attached in the operating room at the completion of the rotator cuff repair. Patients will be randomized intraoperative to receive either the ropivacaine or the saline.
- Saline infusion (Type: PLACEBO_COMPARATOR): 270cc of Normal Saline infusion at 5cc per hour. All patients will receive a reservoir for their catheters containing 280cc of either ropivacaine or saline that will infuse at a rate of 6cc per hour. The reservoirs will be attached in the operating room at the completion of the rotator cuff repair. Patients will be randomized intraoperative to receive either the ropivacaine or the saline.

Based on this trial design, predict the completion outcome and termination type (if applicable).